Illegal Synthetic Opioid Consumption in the Asia-Pacific Region

Quarterly Insights from the RAND Drug Policy Research Center | View in browser

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

March 2021

Asia Pacific map with dots added in a geometric pattern, photo by blackred/Getty Images

Illegal Synthetic Opioid Consumption in the Asia-Pacific Region: Assessing the Risks of a Potential Outbreak

Illegally produced synthetic opioids like fentanyl have contributed to rises in overdose deaths in parts of North America and Europe. While many of these substances are produced in Asia, there is little evidence they have entered markets in the Asia-Pacific region. We assess the risks of a potential outbreak. Read more »

A judge's gavel with bottles of prescription drugs. Photo by CatLane/Getty Images

Photo by CatLane/Getty Images

Opioid Litigation: What's New, and What Does It Mean for Future Litigation?

RAND assembled a distinguished group of attorneys, judges, and scholars for a virtual symposium to discuss opioid litigation and its effects on the future of mass litigation.

Read more »

Ashlee Mason, 26, serves a customer at The Pottery Cannabis Dispensary, as cannabis deliveries increase amid the spread of COVID-19, in Los Angeles, California, April 14, 2020, photo by Lucy Nicholson/Reuters

Photo by Lucy Nicholson/Reuters

Density of Cannabis Outlets Associated with Use Among Young Adults

New study finds that a higher density of both licensed and unlicensed cannabis outlets near young adults’ homes was associated with an increase in the prevalence and frequency of cannabis use.

Read more »

Tomorrow Demands Today: The Campaign for RAND

New Gift to Support Drug Policy Innovation at RAND

A generous gift from engineer and inventor Jack McCauley will support the RAND Drug Policy Research Center and establish the McCauley Chair in Drug Policy Innovation at RAND.

Read more »

Trending Research

Heroin Use Cannot Be Measured Adequately with a General Population Survey

Patient, Prescriber, and Community Factors Associated with Filled Naloxone Prescriptions Among Patients Receiving Buprenorphine

Current U.S. State Cannabis Sales Limits Allow Large Doses for Use or Diversion

DPRC in the News

‘Vodka in Your Coffee Cup’: When Pandemic Drinking Goes Too Far

New York Times

Revealed: How Mexico's Sinaloa Cartel Has Created a Global Network to Rule the Fentanyl Trade

Guardian

'We Are Shipping To The U.S.': Inside China's Online Synthetic Drug Networks

NPR

The War on Drugs Lost This Election. Now What?

Marketplace

Contact

Beau Kilmer

Beau Kilmer

Director, RAND Drug Policy Research Center

McCauley Chair in Drug Policy Innovation, RAND